Clene Inc. – Clene Announces Completion of Patient …

The HEALEY ALS Platform Trial is a perpetual multi-center, randomized, double-blind, placebo-controlled Phase 3 registration program designed to evaluate the efficacy and safety of multiple investigational products in people living with amyotrophic lateral sclerosis (ALS).

https://invest.clene.com/events-and-presentations/Press-Releases/news-details/2021/Clene-Announces-Completion-of-Patient-Enrollment-in-the-HEALEY-ALS-Platform-Trial/default.aspx